Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Chris Cleary is Director at Orchestra Biomed Holdings. OQRO lists 4 transactions filed with the SEC under this name, the latest on Aug 14, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
1
Orchestra Biomed HoldingsOBIO
4 disclosures · Feb 2026 – Aug 2026
Aug 12, 20264,238disclosed Aug 14
DetailsOfficial recordJun 23, 202643Kdisclosed Jun 25
DetailsOfficial recordJun 24, 20263,510disclosed Jun 25
DetailsOfficial recordFeb 5, 2026676disclosed Feb 6
DetailsOfficial recordOn the latest SEC Form 4, dated Aug 12, 2026, Chris Cleary reported holding 29,153 shares of Orchestra Biomed Holdings (OBIO). At the last close of $7 on Nov 13, 2026, that is about $211K. This is the stake disclosed in filings, not a net worth.
As of the latest filing on , Chris Cleary reported holding 29,153 shares of Orchestra Biomed Holdings (OBIO), worth about $211K at the last close of $7 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Orchestra Biomed Holdings OBIO | 29,153 | 29K direct | $7 | $211K | Aug 12, 2026 |
Is this Chris Cleary’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.